Trial intelligence / Profile preview

Effect of Race on Gonadotropin Responses to Gonadal Steroids

NCT00455962Phase 2Completed

Sponsor
Massachusetts General Hospital
Start
Jan 2005
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of estradiol and progesterone (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: LH Peak in Response to Estrogen Positive Feedback at 5 days. Started Jan 2005; status: completed.

02

Drugs

estradiolprogesterone

Beyond the preview

Go deeper on NCT00455962.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00455962.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call